Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.735 USD | -1.42% | +3.33% | +201.77% |
May. 09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
May. 09 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+201.77% | 323M | |
+29.48% | 684B | |
+30.34% | 568B | |
-3.97% | 361B | |
+17.68% | 329B | |
+4.23% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.17% | 166B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Transcript : Nektar Therapeutics - Shareholder/Analyst Call